Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
IMMUImmunomedics, Inc. -0.27%85.0211.0%$713.38m
AMGNAmgen, Inc. 1.77%252.691.3%$670.83m
MRNAModerna, Inc. 0.17%70.640.0%$667.48m
ILMNIllumina, Inc. 0.44%306.863.5%$629.37m
NVAXNovavax, Inc. 0.16%108.1296.5%$606.23m
GILDGilead Sciences, Inc. 1.24%62.871.0%$585.44m
REGNRegeneron Pharmaceuticals, Inc. -2.93%556.832.7%$426.15m
BIIBBiogen, Inc. -0.41%281.181.6%$349.35m
VRTXVertex Pharmaceuticals, Inc. 0.10%270.591.9%$346.37m
SRNESorrento Therapeutics, Inc. -4.40%11.091.5%$306.67m
ALXNAlexion Pharmaceuticals, Inc. 1.01%113.602.0%$282.77m
EXASEXACT Sciences Corp. -0.01%102.0020.7%$271.53m
SGENSeattle Genetics, Inc. 2.23%195.226.0%$232.52m
VXRTVaxart, Inc. -2.86%6.630.0%$192.03m
MNTAMomenta Pharmaceuticals, Inc. -0.02%52.483.0%$177.02m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.